These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18235240)

  • 1. Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations.
    Sakaushi S; Nishida K; Fukada T; Senda-Murata K; Oka S; Sugimoto K
    Cell Cycle; 2008 Feb; 7(4):477-83. PubMed ID: 18235240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live imaging of spindle pole disorganization in docetaxel-treated multicolor cells.
    Sakaushi S; Nishida K; Minamikawa H; Fukada T; Oka S; Sugimoto K
    Biochem Biophys Res Commun; 2007 Jun; 357(3):655-60. PubMed ID: 17448447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered TUBB3 expression contributes to the epothilone response of mitotic cells.
    Narvi E; Jaakkola K; Winsel S; Oetken-Lindholm C; Halonen P; Kallio L; Kallio MJ
    Br J Cancer; 2013 Jan; 108(1):82-90. PubMed ID: 23321512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spindle formation and dynamics of gamma-tubulin and nuclear mitotic apparatus protein distribution during meiosis in pig and mouse oocytes.
    Lee J; Miyano T; Moor RM
    Biol Reprod; 2000 May; 62(5):1184-92. PubMed ID: 10775165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of intracellular MEK1/2 translocation in mouse oocytes: cytoplasmic dynein/dynactin-mediated poleward transport and cyclin B degradation-dependent release from spindle poles.
    Xiong B; Yu LZ; Wang Q; Ai JS; Yin S; Liu JH; OuYang YC; Hou Y; Chen DY; Zou H; Sun QY
    Cell Cycle; 2007 Jun; 6(12):1521-7. PubMed ID: 17507801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.
    Rohena CC; Peng J; Johnson TA; Crews P; Mooberry SL
    Biochem Pharmacol; 2013 Apr; 85(8):1104-14. PubMed ID: 23399639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.
    Bekier ME; Fischbach R; Lee J; Taylor WR
    Mol Cancer Ther; 2009 Jun; 8(6):1646-54. PubMed ID: 19509263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilones and new analogues of the microtubule modulators in taxane-resistant disease.
    Harrison M; Swanton C
    Expert Opin Investig Drugs; 2008 Apr; 17(4):523-46. PubMed ID: 18363517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epothilone D affects cell cycle and microtubular pattern in plant cells.
    Hause G; Lischewski S; Wessjohann LA; Hause B
    J Exp Bot; 2005 Aug; 56(418):2131-7. PubMed ID: 15967777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
    Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
    Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anticancer activity and cytotoxicity of galactosylated epothilone B.
    Gao H; Huang G
    Bioorg Med Chem; 2018 Nov; 26(20):5578-5581. PubMed ID: 30318441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
    Altmann KH; Memmert K
    Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis & antitumor activity of epothilones B and D and their analogs.
    Cheng H; Huang G
    Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Activity of Epothilone D.
    Cheng H; Huang G
    Curr Drug Targets; 2018; 19(15):1866-1870. PubMed ID: 30073925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of isotopically labeled epothilones.
    Ganesh T; Brodie PJ; Banerjee A; Bane S; Kingston DG
    J Labelled Comp Radiopharm; 2014 Feb; 57(2):78-81. PubMed ID: 24307484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between mitotic checkpoint proteins, CENP-E and BubR1, is diminished in epothilone B-resistant A549 cells.
    Yang CP; Liu L; Ikui AE; Horwitz SB
    Cell Cycle; 2010 Mar; 9(6):1207-13. PubMed ID: 20237434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity.
    De Luca M; Brunetto L; Asteriti IA; Giubettini M; Lavia P; Guarguaglini G
    Oncogene; 2008 Nov; 27(51):6539-49. PubMed ID: 18663358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral, non-centrosome-associated microtubules contribute to spindle formation in centrosome-containing cells.
    Tulu US; Rusan NM; Wadsworth P
    Curr Biol; 2003 Oct; 13(21):1894-9. PubMed ID: 14588246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
    Rogalska A; Gajek A; Marczak A
    Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.